Zoledronic Acid Injection
Our range of products include 4 mg Zoledronic Acid Injection IP.
Interested in this product?
Get Best Quote
| Dose/Strength | 4 mg |
| Packaging Type | Vial |
| Brand | Natco |
| Brand Type | Zoldonat |
| Generic Name | Zoledronic Acid |
Description:
- Active IngredientContains Zoledronic Acid 4 mg, a potent third-generation bisphosphonate.
- Bone ProtectionInhibits bone resorption by osteoclasts, making bones stronger and reducing the risk of fractures.
- Treats Bone MetastasesUsed to prevent skeletal-related events (SREs) in patients with cancers that spread to the bone (e.g., breast, prostate, lung cancers, multiple myeloma).
- Hypercalcemia Control:Rapidly lowers high blood calcium levels caused by malignancy (hypercalcemia of malignancy).
- Osteoporosis ManagementUsed in postmenopausal women and men at high risk of fractures, especially when oral bisphosphonates are not suitable.
- Once-Yearly or Monthly DosingLong-acting: administered once a year for osteoporosis or every 3–4 weeks for cancer-related bone issues.
- Intravenous AdministrationGiven by slow IV infusion (over at least 15 minutes), ensuring direct systemic delivery.
- Clinically Proven EfficacyBacked by global clinical studies for safety and effectiveness in reducing bone complications.
- Monitoring RequiredRequires monitoring of renal function, calcium, and phosphate levels before administration.
- Cautions & Side EffectsMay cause flu-like symptoms, joint pain, fatigue, or rare complications like jaw osteonecrosis or renal impairment.
View Complete Details
Yes, I am interested!
All Rights Reserved (Terms of Use)
- Developed and Managed by IndiaMART InterMESH Limited
